title: [Cerivastatin. Which lessons for clinical practice?].
abstract: The event of cerivastatin is the starting point for several methodological issues that, in the era of evidence-based medicine, should be the scientific basis of clinical practice. The article goes into three main issues: the production of evidence about efficacy of drugs, their safety profile through the collection of data about adverse drug reactions and the appropriateness of drug prescription.
authors.affiliation: editor@gimbe.org
authors.forename: A
authors.initials: A
authors.lastname: Cartabellotta
mesh_terms: D011307:Drug Prescriptions; D006801:Humans; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D011725:Pyridines; C086276:cerivastatin
vernacular_title: Cerivastatina. Quale lezione per la pratica clinica?